SLC7A11 and breast cancer: Ungard et al. found silence of SLC7A11 in breast cancer cells delayed onset of cancer‐induced bone pain34; Lee et al. gave a prediction that overexpression of SLC7A11 had a positive correlation of recurrence in patients with oral cavity squamous cell carcinoma.35